Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CSPC Pharmaceutical Group Ltd announces acquisition of 21.43 pct equity interest in Unigene Biotechnology Co. Ltd.

Wednesday, 29 Jan 2014 05:36am EST 

CSPC Pharmaceutical Group Ltd:Says on Jan. 29, the company (as purchaser) entered into the Unigene Equity Transfer Agreement with CCPCL (as vendor).Says the agreement in relation to the sale and purchase of 21.43 pct equity interest in Unigene, at the total consideration of $800,000.Says upon completion of the acquisition, Unigene will become a wholly-owned subsidiary of the company.